Capmatinib

Capmatinib

Capmatinib (INC280) is a potent, selective, and orally active c-Met inhibitor (IC50 = 0.13 nM) that blocks c-Met signaling, suppresses tumor proliferation and migration, and induces apoptosis. It is metabolized primarily by CYP3A4 and aldehyde oxidase. Reagent grade, for research use only.

Molecular structure of the compound BP-43631
    • Unit
    • Price
    • Qty
    • 100 MG
    • $140.00
    • 250 MG
    • $280.00
    • 500 MG
    • $430.00
    • 1 G
    • $640.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire